The latter observation indicated a new molecular mechanism of Hsp27’s cytoprotective role against gemcitabine, involving upregulation of the Akt/mTOR signaling pathway and subsequent inhibition of cancer cell apoptosis. This evidence concerns the gene HSPB1 and cancer.